By Yi Wei Wong Guobang Pharma is seeking to raise up to 15.47 billion Chinese yuan ($2.39 billion) through an initial public offering in Shanghai. ( read original story ...)
Shanghai gets policy boost to promote international renminbi use
ANN): Chinese monetary authorities will support Shanghai to take a lead in the free use of renminbi and explore free capital inflow and outflow and free currency exchange in Shanghai's Lingang Special ... ( read original story ...)
Shanghai gets policy boost to promote intl RMB use
Chinese monetary authorities will support Shanghai to take a lead in the free use of renminbi and explore free capital inflow and outflow and free currency exchange in Shanghai's Lingang Special Area, ... ( read original story ...)
Shanghai’s Pudong gets policy boost toward high-level opening-up Shanghai’s Pudong gets policy boost toward high-level opening-up
Shanghai's Pudong New Area in east China is to be positioned as a "pioneer area for socialist modernization," recent guidelines jointly issued by the Communist Party of China Central Committee and the ... ( read original story ...)
Exclusive-How Didi’s govt relations team navigated myriad regulators, until IPO dustup
Didi Global successfully navigated China's regulatory thicket for years, but the ride-hailing giant's 200-plus government affairs team's reliance ... ( read original story ...)
New developments! Jingke Energy Department pioneer board IPO enters the “inquired” state.
Shanghai Stock Exchange information shows that Jingke Energy Co., Ltd. sprint Kechuangban IPO into the "inquired" state. On June 28th, the Shanghai Stock Exchange formally accepted the application of ... ( read original story ...)
Xianheng International Science&Technology debuts on Shanghai Stock Exchange, rose 44%
Xianheng International Science&Technology (605056) opened at RMB 16.38 on its first day trading on the Shanghai Stock Exchange's Main Board, an increase of 20% from its IPO price of RMB 13.65. ( read original story ...)